Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 2
2015 1
2018 3
2019 3
2020 4
2021 5
2022 7
2023 8
2024 6
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Mycoplasma pneumoniae: gone forever?
Meyer Sauteur PM, Beeton ML; ESGMAC the ESGMAC MAPS study group. Meyer Sauteur PM, et al. Lancet Microbe. 2023 Oct;4(10):e763. doi: 10.1016/S2666-5247(23)00182-9. Epub 2023 Jun 29. Lancet Microbe. 2023. PMID: 37393927 Free article. No abstract available.
Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions.
Meyer Sauteur PM, Beeton ML; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC), and the ESGMAC Mycoplasma pneumoniae Surveillance (MAPS) study group. Meyer Sauteur PM, et al. Lancet Microbe. 2024 Feb;5(2):e100-e101. doi: 10.1016/S2666-5247(23)00344-0. Epub 2023 Nov 23. Lancet Microbe. 2024. PMID: 38008103 Free article. No abstract available.
Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?
Meyer Sauteur PM, Chalker VJ, Berger C, Nir-Paz R, Beeton ML; ESGMAC and the ESGMAC–MyCOVID study group. Meyer Sauteur PM, et al. Lancet Microbe. 2022 Dec;3(12):e897. doi: 10.1016/S2666-5247(22)00190-2. Epub 2022 Aug 11. Lancet Microbe. 2022. PMID: 35964636 Free PMC article. No abstract available.
Pneumonia outbreaks due to re-emergence of Mycoplasma pneumoniae.
Meyer Sauteur PM, Beeton ML; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC), and the ESGMAC Mycoplasma pneumoniae Surveillance (MAPS) study group. Meyer Sauteur PM, et al. Lancet Microbe. 2024 Jun;5(6):e514. doi: 10.1016/S2666-5247(23)00406-8. Epub 2024 Feb 8. Lancet Microbe. 2024. PMID: 38342111 Free article. No abstract available.
Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021.
Meyer Sauteur PM, Beeton ML, Uldum SA, Bossuyt N, Vermeulen M, Loens K, Pereyre S, Bébéar C, Keše D, Day J, Afshar B, Chalker VJ, Greub G, Nir-Paz R, Dumke R; ESGMAC–MyCOVID Study Team. Meyer Sauteur PM, et al. Euro Surveill. 2022 May;27(19):2100746. doi: 10.2807/1560-7917.ES.2022.27.19.2100746. Euro Surveill. 2022. PMID: 35551702 Free PMC article.
Healthcare-associated Infections-Can We Do Better?
Kopsidas I, Collins M, Zaoutis T. Kopsidas I, et al. Pediatr Infect Dis J. 2021 Aug 1;40(8):e305-e309. doi: 10.1097/INF.0000000000003203. Pediatr Infect Dis J. 2021. PMID: 34250978 No abstract available.
The Challenges of Vaccine Trial Participation among Underserved and Hard-to-Reach Communities: An Internal Expert Consultation of the VACCELERATE Consortium.
Poulimeneas D, Koniordou M, Kousi D, Merakou C, Kopsidas I, Tsopela GC, Argyropoulos CD, Themistocleous SC, Shiamakkides G, Constantinou M, Alexandrou A, Noula E, Nearchou A, Salmanton-García J, Stewart FA, Heringer S, Albus K, Álvarez-Barco E, Macken A, Di Marzo R, Luis C, Valle-Simón P, Askling HH, Hellemans M, Spivak O, Davis RJ, Azzini AM, Barta I, Součková L, Jancoriene L, Akova M, Mallon PWG, Olesen OF, Frias-Iniesta J, van Damme P, Tóth K, Cohen-Kandli M, Cox RJ, Husa P, Nauclér P, Marques L, Ochando J, Tacconelli E, Zeitlinger M, Cornely OA, Pana ZD, Zaoutis TE; VACCELERATE Consortium. Poulimeneas D, et al. Among authors: kopsidas i. Vaccines (Basel). 2023 Nov 29;11(12):1784. doi: 10.3390/vaccines11121784. Vaccines (Basel). 2023. PMID: 38140188 Free PMC article.
VACCELERATE Site Network: Real-time definition of clinical study capacity in Europe.
Salmanton-García J, Wipfler P, Valle-Simón P, Merakou C, Kopsidas I, Bethe U, Steinbach A, Spivak O, Součková L, Mendonça MA, Koniordou M, Hellemans M, Frías-Iniesta J, Davis RJ, Barta I, Azzini AM, Askling HH, Argyropoulos CD, Álvarez-Barco E, Akova M, Bonten MMJ, Cohen-Kandli M, Cox RJ, Flisiak R, Husa P, Jancoriene L, Koscalova A, Launay O, Lundgren J, Mallon P, Marques L, Nauclér P, Ochando J, Pana ZD, Tacconelli E, Tóth K, Trelle S, van Damme P, Zaoutis TE, Zeitlinger M, Albus K, Stewart FA, Hofstraat SHI, Bruijning-Verhagen P, Cornely OA; VACCELERATE Consortium. Electronic address: trialsites@vaccelerate.eu. Salmanton-García J, et al. Among authors: kopsidas i. Vaccine. 2023 Jun 13;41(26):3915-3922. doi: 10.1016/j.vaccine.2023.05.006. Epub 2023 May 18. Vaccine. 2023. PMID: 37210309 Free PMC article.
34 results